Clinical Trials Directory

Trials / Completed

CompletedNCT03518645

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds

Optimal Lesion Preparation With Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
KCRI · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study aim : To compare a novel strategy of lesion preparation with noncompliant balloons before implantation of BVS. Hypothesis: Predilatation with non-compliant balloons could facilitate optimal deployment of BVS. By achieving good scaffold apposition a need for post-dilatation could be significantly reduced. This is expected to result in better short- and long-term outcomes.

Detailed description

Study design: Following pre-dilatation a BVS will be implanted and optical coherence tomography (OCT) will be performed in all patients. After OCT post-dilatation with non-compliant balloons might be performed if this is considered necessary by the treating interventionist. Final OCT will be performed in all patients. 1:1 Randomization of two strategies before the implantation of bioresorbable scaffolds: * OPN strategy (study group): pre-dilatation with OPN® NC (non-compliant) Super High Pressure PTCA (percutaneous transluminal coronary angioplasty) balloons * standard strategy (control group): pre-dilatation with a standard (compliant) balloon Enrolment: Randomization of 50 patients * 25 in the OPN strategy (study group) * 25 in the standard strategy (control group)

Conditions

Interventions

TypeNameDescription
DEVICEOPN strategyPredilatation with OPN balloon will be performed as a lesion preparation for BVS Absorb implantation.
DEVICEstandard strategyPredilatation with standard balloon will be performed as a lesion preparation for BVS Absorb implantation.

Timeline

Start date
2015-03-01
Primary completion
2016-12-01
Completion
2018-03-29
First posted
2018-05-08
Last updated
2018-05-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03518645. Inclusion in this directory is not an endorsement.